4//SEC Filing
NABI BIOPHARMACEUTICALS 4
Accession 0001278819-04-000014
$VXRTCIK 0000072444operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:37 PM ET
Size
10.0 KB
Accession
0001278819-04-000014
Insider Transaction Report
Form 4
GURY DAVID J
Director
Transactions
- Exercise/Conversion
Common Stock
2004-04-05$7.06/sh+6,250$44,144→ 503,809.581 total - Exercise/Conversion
Stock Option (right to buy)
2004-04-05−6,250→ 188,817 totalExercise: $7.06Exp: 2010-02-07→ Common Stock (6,250 underlying) - Tax Payment
Common Stock
2004-04-05$16.09/sh−3,496$56,251→ 500,313.581 total
Holdings
- 102,600(indirect: By immediate family)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]The option became exercisable in four equal annual installments ending on February 7, 2004.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 4:37 PM ET
- Size
- 10.0 KB